Simethicone

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Simethicone
Generic name: TARGET BERRY BLAST ANTACID HBG CHEW
Manufacturer: Target
Product type: HUMAN OTC DRUG
SPL set ID: 5245af45-77c7-c95f-e063-6294a90a24f7
SPL ID: 56a7c19f-eb0b-c89d-e063-6294a90aca84
Version: 2
Effective date: 2026-07-15
Source export date: 2026-09-28
Source partition: 14
Source file: https://download.open.fda.gov/drug/label/drug-label-0014-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/db99fd80353afecef4949b48edcaa018be72b966b2360184251eb14df43743f9/drug-label-0014-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:41:09

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M001	openfda.application_number
brand name		Simethicone	openfda.brand_name
generic name		TARGET BERRY BLAST ANTACID HBG CHEW	openfda.generic_name
manufacturer name		Target	openfda.manufacturer_name
ndc	package	11673-549-60	openfda.package_ndc
ndc	product	11673-549	openfda.product_ndc
ndc11	package	11673054960	derived:openfda.package_ndc
rxcui		1492387	openfda.rxcui
spl id		56a7c19f-eb0b-c89d-e063-6294a90aca84	id
spl set id		5245af45-77c7-c95f-e063-6294a90a24f7	set_id
unii		H0G9379FGK	openfda.unii
unii		92RU3N3Y1O	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not use if you have ever had an allergic reaction to this product or any of its ingredients. Do not take more than 5 chewable tablets in a 24-hour period, or use the maximum dosage for this product for more than 2 weeks, except under the advice and supervision of a physician.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.